Zobrazeno 1 - 9
of 9
pro vyhledávání: '"James Patrick Buteau"'
Autor:
Genevieve Loos, James Patrick Buteau, Justin Oh, Kendrick Koo, Sylvia Van Dyk, Nathan Lawrentschuk, Declan Murphy, Michael S Hofman, Scott Willimas, Sarat Chander
Purpose Brachytherapy as monotherapy is a recommended treatment option for men with low to intermediate risk prostate cancer, achieving biochemical progression-free survival rates >95% at 5 years. Local recurrence is difficult to identify due to sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b37bb8028344bdd74db2bfe195cce258
https://doi.org/10.21203/rs.3.rs-2280588/v1
https://doi.org/10.21203/rs.3.rs-2280588/v1
Autor:
Louise Kathleen Kostos, James Patrick Buteau, Grace Kong, Theresa Yeung, Juliana Di Iulio, Michael T Fahey, Heidi Fettke, Luc Furic, Michael S Hofman, Arun Azad
Publikováno v:
Journal of Clinical Oncology. 41:TPS278-TPS278
TPS278 Background: [177Lu]Lu-PSMA-617 was recently FDA-approved for use in the post-taxane, post-antiandrogen setting in pts with mCRPC. Despite conferring a survival benefit, for many the treatment response is short, and progression is inevitable. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4e9d274d61ff77e509e45383c027fd1
https://doi.org/10.1200/jco.2023.41.6_suppl.tps278
https://doi.org/10.1200/jco.2023.41.6_suppl.tps278
Autor:
James Patrick Buteau, Louise Kathleen Kostos, Ramin Alipour, Price Jackson, Lachlan McIntosh, Brittany Emmerson, Mohammad B Haskali, Theresa Yeung, Sophia Xie, Elizabeth Medhurst, Rajeev Ravi, Brian D. Gonzalez, Heidi Fettke, Nicole Ng, Maria Docanto, Patricia Bukczynska, Benjamin Blyth, Luc Furic, Arun Azad, Michael S Hofman
Publikováno v:
Journal of Clinical Oncology. 41:TPS281-TPS281
TPS281 Background: [177Lu]Lu-PSMA is an effective class of therapy for men with metastatic castration-resistant prostate cancer (mCRPC); however, progression is inevitable. The limited durability of response is partially explained by the presence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c98f01a7d11553724c3c6c8b56e88af
https://doi.org/10.1200/jco.2023.41.6_suppl.tps281
https://doi.org/10.1200/jco.2023.41.6_suppl.tps281
Autor:
James Patrick Buteau, Daniel Moon, Michael T Fahey, Matthew Roberts, James Thompson, Declan G. Murphy, Nathan Papa, Catherine Mitchell, Veeru Kasivisvanathan, Phillip Stricker, Jonathan O'Brien, William Counter, Gaurav Sharma, Shikha Agrawal, Bao Ho, Theresa Yeung, Richard De Abreu Lourenço, Haryana M. Dhillon, Michael S Hofman, Louise Emmett
Publikováno v:
Journal of Clinical Oncology. 41:TPS397-TPS397
TPS397 Background: Multi-parametric magnetic resonance imaging (MRI) has an established role for the diagnosis of clinically significant prostate cancer (sPCa), with superior diagnostic accuracy compared with transrectal ultrasound guided prostate bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09d196e7822eb1ca59def2b3fa7ef9fd
https://doi.org/10.1200/jco.2023.41.6_suppl.tps397
https://doi.org/10.1200/jco.2023.41.6_suppl.tps397
Autor:
Louise Kathleen Kostos, William Yu Ching Lai, Peter Lambroglou, Elizabeth Medhurst, James Patrick Buteau, Shahneen Sandhu, Ben Tran, Lavinia Anne Spain, Ciara Conduit, Roslyn Wallace, Ramin Alipour, Timothy J. Akhurst, Grace Kong, Anthony Cardin, Javad Saghebi, Aravind Ravi Kumar, Michael S Hofman, Arun Azad
Publikováno v:
Journal of Clinical Oncology. 41:77-77
77 Background: [177Lu]Lu-PSMA (LuPSMA) is currently FDA-approved for use in the post-taxane, post-antiandrogen setting in pts with mCRPC. Little is known about the efficacy of treatment in pts with subsequent progression after LuPSMA. In this single-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c857bd4c6a9a327b50ded5ac6f25112e
https://doi.org/10.1200/jco.2023.41.6_suppl.77
https://doi.org/10.1200/jco.2023.41.6_suppl.77
Autor:
Louise Kathleen Kostos, James Patrick Buteau, Theresa Yeung, Sophia Xie, Juliana Di Iulio, Anthony Cardin, Katie Owen, Heidi Fettke, Kwang Y Chin, Brittany Emmerson, Mohammad B Haskali, Belinda Parker, Luc Furic, Arun Azad, Michael S Hofman
Publikováno v:
Journal of Clinical Oncology. 41:TPS280-TPS280
TPS280 Background: [177Lu]Lu-PSMA-I&T (LuPSMA) is a small molecule radioligand that delivers radiation via beta-particulate emission to cells expressing prostate-specific membrane antigen (PSMA). Despite a survival benefit in mCRPC, responses for man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c858b31d10f3d96b1323f320d58d3920
https://doi.org/10.1200/jco.2023.41.6_suppl.tps280
https://doi.org/10.1200/jco.2023.41.6_suppl.tps280
Autor:
Price, Jackson, Michael, Hofman, Lachlan, McIntosh, James Patrick, Buteau, Aravind, Ravi Kumar
Publikováno v:
Seminars in nuclear medicine. 52(2)
Radionuclide therapy using the small molecule PSMA bound to the beta-emitting radionuclide, Lutetium-177 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82a17c3966a1f2d341378b0fa3a38602
https://pubmed.ncbi.nlm.nih.gov/34893320
https://pubmed.ncbi.nlm.nih.gov/34893320
Publikováno v:
Journal of Nuclear Cardiology. 23:1501-1503
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dd5907be04a206f07395629babc8fa0
https://doi.org/10.1007/s12350-016-0459-6
https://doi.org/10.1007/s12350-016-0459-6
Autor:
Edmond Rizcallah, Khun Visith Keu, Eric Turcotte, Etienne Rousseau, Eugenia Ducharne Asuaje, James Patrick Buteau, Carlos Andrés Ochoa
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 42:364-365
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3434c4caab71a3dd5c2a2419afa4c28
https://doi.org/10.1007/s00259-014-2923-3
https://doi.org/10.1007/s00259-014-2923-3